Active monomers of human β-tryptase have expanded substrate specificities

International Immunopharmacology

Volumn 7, Issue 14, 2007, Pages 1900-1908

  Fukuoka, Yoshihiro ^a   Schwartz, Lawrence B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Tryptase; Human; Mast cells

Indexed keywords

BETA TRYPTASE; CELL PROTEIN; COMPLEMENT COMPONENT C3; ENZYME PRECURSOR; FIBRINOGEN; FIBRONECTIN; GENE PRODUCT; HEPARIN; HISTAMINE; MONOMER; PROTEINASE ACTIVATED RECEPTOR 2; PROTEOGLYCAN; PROUROKINASE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; STROMELYSIN; TRYPSIN; TRYPTASE; UNCLASSIFIED DRUG;

ANAPHYLACTIC SHOCK; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME RELEASE; ENZYME SPECIFICITY; GENE; HUMAN; INFLAMMATION; LUNG LAVAGE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY TRACT DISEASE; TPSAB1 GENE; TPSB2 GENE;

ANAPHYLAXIS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHITIS; CELL DEGRANULATION; DIMERIZATION; ENZYME ACTIVATION; ENZYME STABILITY; HEPARIN; HUMANS; HYDROGEN-ION CONCENTRATION; MAST CELLS; MOLECULAR WEIGHT; PROTEIN STRUCTURE, QUATERNARY; PROTEOGLYCANS; SERINE PROTEINASE INHIBITORS; SUBSTRATE SPECIFICITY; TRYPTASES;

EID: 36249008582     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.07.007     Document Type: Article

References (79)

1. Schwartz L.B., Lewis R.A., and Austen K.F. Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem 256 (1981) 11939-11943
2. Schwartz L.B., and Bradford T.R. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J Biol Chem 261 (1986) 7372-7379
3. Schwartz L.B., Lewis R.A., Seldin D., and Austen K.F. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol 126 (1981) 1290-1294
4. Schwartz L.B. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am 26 (2006) 451-463
5. Pereira P.J., Bergner A., Macedo-Ribeiro S., Huber R., Matschiner G., Fritz H., et al. Human β-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 392 (1998) 306-311
6. Sommerhoff C.P., Bode W., Pereira P.J., Stubbs M.T., Sturzebecher J., Piechottka G.P., et al. The structure of the human betaII-tryptase tetramer: fo(u)r better or worse. Proc Natl Acad Sci U S A 96 (1999) 10984-10991
7. Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., and Pavord I.D. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 346 (2002) 1699-1705
8. Oskeritzian C.A., Zhao W., Min H.K., Xia H.Z., Pozez A., Kiev J., et al. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J Allergy Clin Immunol 115 (2005) 1162-1168
9. Goldstein S.M., Leong J., Schwartz L.B., and Cooke D. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes: tryptase resides in a complex distinct from chymase and carboxypeptidase. J Immunol 148 (1992) 2475-2482
10. Urata H., Karnik S.S., Graham R.M., and Husain A. Dipeptide processing activates recombinant human prochymase. J Biol Chem 268 (1993) 24318-24322
11. Murakami M., Karnik S.S., and Husain A. Human prochymase activation. A novel role for heparin in zymogen processing. J Biol Chem 270 (1995) 2218-2223
12. Sakai K., Ren S., and Schwartz L.B. A novel heparin-dependent processing pathway for human tryptase: autocatalysis followed by activation with dipeptidyl peptidase I. J Clin Invest 97 (1996) 988-995
13. Wintroub B.U., Schechter N.B., Lazarus G.S., Kaempfer C.E., and Schwartz L.B. Angiotensin I conversion by human and rat chymotryptic proteinases. J Invest Dermatol 83 (1984) 336-339
14. Urata H., Kinoshita A., Misono K.S., Bumpus F.M., and Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265 (1990) 22348-22357
15. Kofford M.W., Schwartz L.B., Schechter N.M., Yager D.R., Diegelmann R.F., and Graham M.F. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J Biol Chem 272 (1997) 7127-7131
16. Zhao W., Oskeritzian C.A., Pozez A.L., and Schwartz L.B. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. J Immunol 175 (2005) 2635-2642
17. TC type of human mast cell. J Immunol 145 (1990) 2652-2661
18. Goldstein S.M., Kaempfer C.E., Kealey J.T., and Wintroub B.U. Human mast cell carboxypeptidase: purification and characterization. J Clin Invest 83 (1989) 1630-1666
19. TC cells. J Immunol 147 (1991) 247-253
20. Natsuaki M., Stewart C.-B., Vanderslice P., Schwartz L.B., Wintroub B.U., Rutter W.J., et al. Human skin mast cell carboxypeptidase: functional characterization, cDNA cloning, and genealogy. J Invest Dermatol 99 (1992) 138-145
21. Reynolds D.S., Gurley D.S., and Austen K.F. Cloning and characterization of the novel gene for mast cell carboxypeptidase A. J Clin Invest 89 (1992) 273-282
22. Henningsson F., Ledin J., Lunderius C., Wilen M., Hellman L., and Pejler G. Altered storage of proteases in mast cells from mice lacking heparin: a possible role for heparin in carboxypeptidase A processing. Biol Chem 383 (2002) 793-801
23. Miller J.S., Westin E.H., and Schwartz L.B. Cloning and characterization of complementary DNA for human tryptase. J Clin Invest 84 (1989) 1188-1195
24. Miller J.S., Moxley G., and Schwartz L.B. Cloning and characterization of a second complementary DNA for human tryptase. J Clin Invest 86 (1990) 864-870
25. Pallaoro M., Fejzo M.S., Shayesteh L., Blount J.L., and Caughey G.H. Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3. J Biol Chem 274 (1999) 3355-3362
26. Huang C., Li L., Krilis S.A., Chanasyk K., Tang Y., Li Z., et al. Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft. J Biol Chem 274 (1999) 19670-19676
27. Schwartz L.B., Min H.K., Ren S., Xia H.Z., Hu J., Zhao W., et al. Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, mono-Mac-6 cells, and human skin-derived mast cells. J Immunol 170 (2003) 5667-5673
28. Forsberg E., Pejler G., Ringvall M., Lunderius C., Tomasini-Johansson B., Kusche-Gullberg M., et al. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 400 (1999) 773-776
29. Wong G.W., Tang Y.Z., and Stevens R.L. Cloning of the human homolog of mouse transmembrane tryptase. Int Arch Allergy Immunol 118 (1999) 419-421
30. Caughey G.H., Raymond W.W., Blount J.L., Hau L.W.T., Pallaoro M., Wolters P.J., et al. Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families. J Immunol 164 (2000) 6566-6575
31. Wang H.W., McNeil H.P., Husain A., Liu K., Tedla N., Thomas P.S., et al. delta tryptase is expressed in multiple human tissues, and a recombinant form has proteolytic activity. J Immunol 169 (2002) 5145-5152
32. Min H.K., Kambe N., and Schwartz L.B. Human mouse mast cell protease 7-like tryptase genes are pseudogenes. J Allergy Clin Immunol 107 (2001) 315-321
33. Wong G.W., Yasuda S., Madhusudhan M.S., Li L., Yang Y., Krilis S.A., et al. Human tryptase epsilon (PRSS22), a new member of the chromosome 16p13.3 family of human serine proteases expressed in airway epithelial cells. J Biol Chem 276 (2001) 49169-49182
34. Alter S.C., Kramps J.A., Janoff A., and Schwartz L.B. Interactions of human mast cell tryptase with biological protease inhibitors. Arch Biochem Biophys 276 (1990) 26-31
35. Clark J.M., Abraham W.M., Fishman C.E., Forteza R., Ahmed A., Cortes A., et al. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am J Respir Crit Care Med 152 (1995) 2076-2083
36. Wright C.D., Havill A.M., Middleton S.C., Kashem M.A., Dripps D.J., Abraham W.M., et al. Inhibition of allergen-induced pulmonary responses by the selective tryptase inhibitor 1,5-bis-{4-[(3-carbamimidoyl-benzenesulfonylamino)-methyl]phenoxy}-pentane (AMG-126737). Biochem Pharmacol 58 (1999) 1989-1996
37. Sylvin H., Dahlback M., Van D.P.I., and Alving K. The tryptase inhibitor APC-366 reduces the acute airway response to allergen in pigs sensitized to Ascaris suum. Clin Exp Allergy 32 (2002) 967-971
38. Oh S.W., Pae C.I., Lee D.K., Jones F., Chiang G.K., Kim H.O., et al. Tryptase inhibition blocks airway inflammation in a mouse asthma model. J Immunol 168 (2002) 1992-2000
39. Schwartz L.B., Bradford T.R., Littman B.H., and Wintroub B.U. The fibrinogenolytic activity of purified tryptase from human lung mast cells. J Immunol 135 (1985) 2762-2767
40. Ren S., Lawson A.E., Carr M., Baumgarten C.M., and Schwartz L.B. Human tryptase fibrinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti-tryptase monoclonal antibody B12. J Immunol 159 (1997) 3540-3548
41. Thomas V.A., Wheeless C.J., Stack M.S., and Johnson D.A. Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption. Biochemistry 37 (1998) 2291-2298
42. Gruber B.L., Marchese M.J., Suzuki K., Schwartz L.B., Okada Y., Nagase H., et al. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest 84 (1989) 1657-1662
43. Schwartz L.B., Maier M., and Spragg J. Interaction of human low molecular weight kininogen with human mast cell tryptase. Adv Exp Med Biol 198 (1986) 105-111
44. Maier M., Spragg J., and Schwartz L.B. Inactivation of human high molecular weight kininogen by human mast cell tryptase. J Immunol 130 (1983) 2352-2356
45. Proud D., Siekierski E.S., and Bailey G.S. Identification of human lung mast cell kininogenase as tryptase and relevance of tryptase kininogenase activity. Biochem Pharmacol 37 (1988) 1473-1480
46. Walls A.F., Bennett A.R., Sueiras-Diaz J., and Olsson H. The kininogenase activity of human mast cell tryptase. Biochem Soc Trans 20 (1992) 260S
47. Lohi J., Harvima I., and Keski-Oja J. Pericellular substrates of human mast cell tryptase: 72,000 Dalton gelatinase and fibronectin. J Cell Biochem 50 (1992) 337-349
48. Stack M.S., and Johnson D.A. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J Biol Chem 269 (1994) 9416-9419
49. Schwartz L.B., Kawahara M.S., Hugli T.E., Vik D., Fearon D.T., and Austen K.F. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol 130 (1983) 1891-1895
50. Caughey G.H., Leidig F., Viro N.F., and Nadel J.A. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther 244 (1988) 133-137
51. Walls A.F., Brain S.D., Desai A., Jose P.J., Hawkings E., Church M.K., et al. Human mast cell tryptase attenuates the vasodilator activity of calcitonin gene-related peptide. Biochem Pharmacol 43 (1992) 1243-1248
52. Hartmann T., Ruoss S.J., Raymond W.W., Seuwen K., and Caughey G.H. Human tryptase as a potent, cell-specific mitogen: role of signaling pathways in synergistic responses. Am J Physiol Lung Cell Mol Physiol 262 (1992) L528-L534
53. Cairns J.A., and Walls A.F. Mast cell tryptase is a mitogen for epithelial cells-stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol 156 (1996) 275-283
54. Brown J.K., Tyler C.L., Jones C.A., Ruoss S.J., Hartmann T., and Caughey G.H. Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells. Am J Respir Cell Mol Biol 13 (1995) 227-236
55. Cairns J.A., and Walls A.F. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 99 (1997) 1313-1321
56. Gruber B.L., Kew R.R., Jelaska A., Marchese M.J., Garlick J., Ren S.L., et al. Human mast cells activate fibroblasts-tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 158 (1997) 2310-2317
57. Mirza H., Schmidt V.A., Derian C.K., Jesty J., and Bahou W.F. Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell α- or β-tryptases. Blood 90 (1997) 3914-3922
58. Mirza H., Yatsula V., and Bahou W.F. The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. J Clin Invest 97 (1996) 1705-1714
59. Akers I.A., Parsons M., Hill M.R., Hollenberg M.D., Sanjar S., Laurent G.J., et al. Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am J Physiol Lung Cell Mol Physiol 278 (2000) L193-L201
60. Berger P., Perng D.W., Thabrew H., Compton S.J., Cairns J.A., McEuen A.R., et al. Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. J Appl Physiol 91 (2001) 1372-1379
61. Schmidlin F., Amadesi S., Vidil R., Trevisani M., Martinet N., Caughey G., et al. Expression and function of proteinase-activated receptor 2 in human bronchial smooth muscle. Am J Respir Crit Care Med 164 (2001) 1276-1281
62. Huang C., De Sanctis G.T., O'Brien P.J., Mizgerd J.P., Friend D.S., Drazen J.M., et al. Evaluation of the substrate specificity of human mast cell tryptase beta I and demonstration of its importance in bacterial infections of the lung. J Biol Chem 276 (2001) 26276-26284
63. Compton S.J., Renaux B., Wijesuriya S.J., and Hollenberg M.D. Glycosylation and the activation of proteinase-activated receptor 2 (PAR(2)) by human mast cell tryptase. Br J Pharmacol 134 (2001) 705-718
64. Compton S.J., Sandhu S., Wijesuriya S.J., and Hollenberg M.D. Glycosylation of human proteinase-activated receptor-2 (PAR-2): role in cell surface expression and signalling. Biochem J 368 (2002) 495-505
65. Sambrano G.R., Huang W., Faruqi T., Mahrus S., Craik C., and Coughlin S.R. Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 275 (2000) 6819-6823
66. Schechter N.M., Brass L.F., Lavker R.M., and Jensen P.J. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J Cell Physiol 176 (1998) 365-373
67. Schwartz L.B., Bradford T.R., Lee D.C., and Chlebowski J.F. Immunologic and physicochemical evidence for conformational changes occurring on conversion of human mast cell tryptase from active tetramer to inactive monomer: production of monoclonal antibodies recognizing active tryptase. J Immunol 144 (1990) 2304-2311
68. Schechter N.M., Eng G.Y., and McCaslin D.R. Human skin tryptase: kinetic characterization of its spontaneous inactivation. Biochemistry 32 (1993) 2617-2625
69. Schechter N.M., Eng G.Y., Selwood T., and McCaslin D.R. Structural changes associated with the spontaneous inactivation of the serine proteinase human tryptase. Biochemistry 34 (1995) 10628-10638
70. Addington A.K., and Johnson D.A. Inactivation of human lung tryptase: evidence for a re-activatable tetrameric intermediate and active monomers. Biochemistry 35 (1996) 13511-13518
71. Ren S.L., Sakai K., and Schwartz L.B. Regulation of human mast cell β-tryptase: conversion of inactive monomer to active tetramer at acid pH. J Immunol 160 (1998) 4561-4569
72. Fukuoka Y., and Schwartz L.B. Human beta-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors. Biochemistry 43 (2004) 10757-10764
73. Hallgren J., Spillmann D., and Pejler G. Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell tryptase, mouse mast cell protease-6: formation of active tryptase monomers in the presence of low molecular weight heparin. J Biol Chem 276 (2001) 42774-42781
74. Fajardo I., and Pejler G. Formation of active monomers from tetrameric human beta-tryptase. Biochem J 369 (2003) 603-610
75. Fukuoka Y., and Schwartz L.B. The B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized beta-tryptase to form monomers that are inactive at neutral pH and active at acidic pH. J Immunol 176 (2006) 3165-3172
76. Selwood T., Smolensky H., McCaslin D.R., and Schechter N.M. The interaction of human tryptase-beta with small molecule inhibitors provides new insights into the unusual functional instability and quaternary structure of the protease. Biochemistry 44 (2005) 3580-3590
77. Hunt J.F., Fang K., Malik R., Snyder A., Malhotra N., Platts-Mills T.A., et al. Endogenous airway acidification. Implications for asthma pathophysiology. [see comments]. Am J Respir Crit Care Med 161 (2000) 694-699
78. Gaston B., and Hunt J.F. How acidopneic is my patient? A new question in the pulmonary laboratory. Am J Respir Crit Care Med 165 (2002) 1349-1350
79. Gillies R.J., Raghunand N., Karczmar G.S., and Bhujwalla Z.M. MRI of the tumor microenvironment. J Magn Reson Imaging 16 (2002) 430-450